COMPANY INFO
MEDTECH – Switzerland
Current stage: Exit
COMPANY PROFILE
Aïmago provided diagnostic imaging solutions to visualize microcirculation, and related functional and metabolic parameters for hospitals. In 2014, Novadaq Technologies has signed on the dotted line to acquire privately-held the Swiss company to broaden its product and patent portfolio. Aïmago was founded in 2008 as a spin-off from École Polytechnique Fédérale de Lausanne, and among assets being acquired are patents licensed from the Swiss academic and research institution.